Image de couverture de livre

Marine Streptomyces-Derived Lipids Inhibit SARS-CoV-2 3CLpro through In Vitro and Predicted Multi-Site Binding Mechanisms Supporting Information

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Dalisay, Doralyn
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Marine -Derived Lipids Inhibit SARS-CoV-2 3CLpro Through In Vitro and Predicted Multi-Site Binding Mechanisms.
par: Dalisay, Doralyn S, et autres
Publié: (2026)

Identification of SARS-CoV-2 3CLpro inhibitors from marine actinomycetes through integrated phylogeny-based metabolomics with functional screening and bioinformatic analysis.
par: Dalisay, Doralyn S, et autres
Publié: (2025)

Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease
par: Wenjin Li, et autres
Publié: (2024)

Polysialosides Outperform Sulfated Analogs for Binding with SARS‐CoV‐2
par: Vinod Khatri, et autres
Publié: (2025)

Selection and Characterization of SARS‐CoV‐2 Spike Binding Clickmers
par: Nima Moradzadeh, et autres
Publié: (2026)

Marine-Derived Peptides from as Potential SARS-CoV-2 Mpro Inhibitors: An Approach.
par: Cañedo-Figueroa, David Mauricio, et autres
Publié: (2025)

SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment
par: Sara Protić, et autres
Publié: (2024)

Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot with Thermodynamics-Driven Machine Learning
par: Ivonina, Mariia, et autres
Publié: (2026)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
par: Kuldeep Singh Patel
Publié: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
par: Swapna Thomas, et autres
Publié: (2024)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
par: Gints Kalnins, et autres
Publié: (2024)

Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations
par: Johanna Schillings, et autres
Publié: (2024)

Deep Neural Network-Based Prediction of B-Cell Epitopes for SARS-CoV and SARS-CoV-2: Enhancing Vaccine Design through Machine Learning
par: Shi, Xinyu, et autres
Publié: (2024)

COVID ‐19 Dry Mouth Induced by SARS ‐ CoV ‐2 Not Binding Directly to ACE2 but Interacting Electrostatically With Lipid Raft in Salivary Glands
par: Hironori Tsuchiya
Publié: (2025)

AbAffinity: A Large Language Model for Predicting Antibody Binding Affinity against SARS-CoV-2
par: Ashraf, Faisal Bin, et autres
Publié: (2026)

Front Cover: Copper(II) Inhibition of the SARS‐CoV‐2 Main Protease
par: Roberto A. Garza‐López, et autres
Publié: (2025)

Corrigendum: Corrigendum: Binding of Glycans to the SARS CoV‐2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and Selectivity
Publié: (2024)

Mechanisms and safety of air plasma inactivated SARS-CoV-2
par: Wang, Guiqiang, et autres
Publié: (2023)

LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants
par: Zhenfei Bi, et autres
Publié: (2025)

Navigating the Universe of the Web Information in the Multimedia Classroom.
par: Edwards, Doralyn H.
Publié: (1997)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
par: Monica Rosas‐Lemus, et autres
Publié: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
par: Deborah L Burnett, et autres
Publié: (2026)

In Vitro Diagnostics for SARS ‐ CoV ‐2 Infection Authorized in the United States and Approved in Japan
par: Mayumi Idei, et autres
Publié: (2025)

Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP
par: Tingfu Du, et autres
Publié: (2026)

Predicting potential SARS-CoV-2 spillover and spillback in animals
par: Tan, Zi Hian, et autres
Publié: (2024)

Immunoassay Detection of SARS ‐ CoV ‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
par: Robert M. Hnasko, et autres
Publié: (2025)

SARS-CoV-2 and Saliva: an update
par: Muniz, Isis de Araújo Ferreira, et autres
Publié: (2020)

Structural Immunology of SARS‐CoV‐2
par: Meng Yuan, et autres
Publié: (2024)

Demografía y SARS-CoV-2
par: Manuel Ordorica Mellado
Publié: (2021)

Pandemia por SARS-CoV-2
par: Erina Petrera
Publié: (2020)

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
par: Timoteo Delgado‐Maldonado, et autres
Publié: (2025)

Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”
Publié: (2026)

SARS-CoV-2 and ACE2 nexus
par: Arifuddin, Mehnaaz Sameera
Publié: (2020)

Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD
par: Neander, Lenard, et autres
Publié: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
par: Alexandre Hassanin, et autres
Publié: (2024)

Impact of SARS-CoV-2 on the Coronavirus Literature through Dynamic Topics
par: Ibai Guillen Pacho
Publié: (2022)

PETRA: Pretrained Evolutionary Transformer for SARS-CoV-2 Mutation Prediction
par: Zou, Xu
Publié: (2025)

Predicting SARS‐CoV‐2 Infection With Graph Attention Capsule Networks
par: Runjie Zhu, et autres
Publié: (2026)

Amphibian‐Derived Peptides as Natural Inhibitors of SARS‐CoV‐2 Main Protease (M pro ): A Combined In Vitro and In Silico Approach
par: Roque Spinelli, et autres
Publié: (2025)

Computational Repurposing of Relatively Large Drugs for the Receptor Binding Domain of SARS‐CoV‐2 Spike Protein
par: Mansour H. Almatarneh, et autres
Publié: (2025)